- call +1-201-465-4211
- email sales@mrinsights.biz
Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Scope of the Report:
This report focuses on the Female Contraceptive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
The Americas will be the major revenue contributor to the contraceptive pills market throughout the forecast period. In this region, US will be the major contributor owing to the increased demand and adoption of female contraceptive devices.
The worldwide market for Female Contraceptive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Female Contraceptive Devices
Female Contraceptive Drugs
Market Segment by Applications, can be divided into
Online Stores
Retail Outlets
There are 15 Chapters to deeply display the global Female Contraceptive market.
Chapter 1, to describe Female Contraceptive Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Female Contraceptive, with sales, revenue, and price of Female Contraceptive, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Female Contraceptive, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Female Contraceptive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Female Contraceptive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Female Contraceptive Introduction
1.2 Market Analysis by Type
1.2.1 Female Contraceptive Devices
1.2.2 Female Contraceptive Drugs
1.3 Market Analysis by Applications
1.3.1 Online Stores
1.3.2 Retail Outlets
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Female Contraceptive Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Female Contraceptive Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Female Contraceptive Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Female Contraceptive Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Okamoto Industries
2.5.1 Business Overview
2.5.2 Female Contraceptive Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Okamoto Industries Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Reckitt Benckiser
2.6.1 Business Overview
2.6.2 Female Contraceptive Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Reckitt Benckiser Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Lupin Pharmaceuticals
2.7.1 Business Overview
2.7.2 Female Contraceptive Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Foundation Consumer Healthcare
2.8.1 Business Overview
2.8.2 Female Contraceptive Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceuticals
2.9.1 Business Overview
2.9.2 Female Contraceptive Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ansell
2.10.1 Business Overview
2.10.2 Female Contraceptive Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ansell Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ferring Pharmaceuticals
2.11.1 Business Overview
2.11.2 Female Contraceptive Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Fuji Latex
2.12.1 Business Overview
2.12.2 Female Contraceptive Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Fuji Latex Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Janssen Pharmaceuticals
2.13.1 Business Overview
2.13.2 Female Contraceptive Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Female Contraceptive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Female Contraceptive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Female Contraceptive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Female Contraceptive Manufacturer Market Share in 2017
3.3.2 Top 6 Female Contraceptive Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Female Contraceptive Market Analysis by Regions
4.1 Global Female Contraceptive Sales, Revenue and Market Share by Regions
4.1.1 Global Female Contraceptive Sales and Market Share by Regions (2013-2018)
4.1.2 Global Female Contraceptive Revenue and Market Share by Regions (2013-2018)
4.2 North America Female Contraceptive Sales and Growth Rate (2013-2018)
4.3 Europe Female Contraceptive Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Female Contraceptive Sales and Growth Rate (2013-2018)
4.5 South America Female Contraceptive Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Female Contraceptive Sales and Growth Rate (2013-2018)
5 North America Female Contraceptive by Countries
5.1 North America Female Contraceptive Sales, Revenue and Market Share by Countries
5.1.1 North America Female Contraceptive Sales and Market Share by Countries (2013-2018)
5.1.2 North America Female Contraceptive Revenue and Market Share by Countries (2013-2018)
5.2 United States Female Contraceptive Sales and Growth Rate (2013-2018)
5.3 Canada Female Contraceptive Sales and Growth Rate (2013-2018)
5.4 Mexico Female Contraceptive Sales and Growth Rate (2013-2018)
6 Europe Female Contraceptive by Countries
6.1 Europe Female Contraceptive Sales, Revenue and Market Share by Countries
6.1.1 Europe Female Contraceptive Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Female Contraceptive Revenue and Market Share by Countries (2013-2018)
6.2 Germany Female Contraceptive Sales and Growth Rate (2013-2018)
6.3 UK Female Contraceptive Sales and Growth Rate (2013-2018)
6.4 France Female Contraceptive Sales and Growth Rate (2013-2018)
6.5 Russia Female Contraceptive Sales and Growth Rate (2013-2018)
6.6 Italy Female Contraceptive Sales and Growth Rate (2013-2018)
7 Asia-Pacific Female Contraceptive by Countries
7.1 Asia-Pacific Female Contraceptive Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Female Contraceptive Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Female Contraceptive Revenue and Market Share by Countries (2013-2018)
7.2 China Female Contraceptive Sales and Growth Rate (2013-2018)
7.3 Japan Female Contraceptive Sales and Growth Rate (2013-2018)
7.4 Korea Female Contraceptive Sales and Growth Rate (2013-2018)
7.5 India Female Contraceptive Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Female Contraceptive Sales and Growth Rate (2013-2018)
8 South America Female Contraceptive by Countries
8.1 South America Female Contraceptive Sales, Revenue and Market Share by Countries
8.1.1 South America Female Contraceptive Sales and Market Share by Countries (2013-2018)
8.1.2 South America Female Contraceptive Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Female Contraceptive Sales and Growth Rate (2013-2018)
8.3 Argentina Female Contraceptive Sales and Growth Rate (2013-2018)
8.4 Colombia Female Contraceptive Sales and Growth Rate (2013-2018)
9 Middle East and Africa Female Contraceptive by Countries
9.1 Middle East and Africa Female Contraceptive Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Female Contraceptive Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Female Contraceptive Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Female Contraceptive Sales and Growth Rate (2013-2018)
9.3 UAE Female Contraceptive Sales and Growth Rate (2013-2018)
9.4 Egypt Female Contraceptive Sales and Growth Rate (2013-2018)
9.5 Nigeria Female Contraceptive Sales and Growth Rate (2013-2018)
9.6 South Africa Female Contraceptive Sales and Growth Rate (2013-2018)
10 Global Female Contraceptive Market Segment by Type
10.1 Global Female Contraceptive Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Female Contraceptive Sales and Market Share by Type (2013-2018)
10.1.2 Global Female Contraceptive Revenue and Market Share by Type (2013-2018)
10.2 Female Contraceptive Devices Sales Growth and Price
10.2.1 Global Female Contraceptive Devices Sales Growth (2013-2018)
10.2.2 Global Female Contraceptive Devices Price (2013-2018)
10.3 Female Contraceptive Drugs Sales Growth and Price
10.3.1 Global Female Contraceptive Drugs Sales Growth (2013-2018)
10.3.2 Global Female Contraceptive Drugs Price (2013-2018)
11 Global Female Contraceptive Market Segment by Application
11.1 Global Female Contraceptive Sales Market Share by Application (2013-2018)
11.2 Online Stores Sales Growth (2013-2018)
11.3 Retail Outlets Sales Growth (2013-2018)
12 Female Contraceptive Market Forecast (2018-2023)
12.1 Global Female Contraceptive Sales, Revenue and Growth Rate (2018-2023)
12.2 Female Contraceptive Market Forecast by Regions (2018-2023)
12.2.1 North America Female Contraceptive Market Forecast (2018-2023)
12.2.2 Europe Female Contraceptive Market Forecast (2018-2023)
12.2.3 Asia-Pacific Female Contraceptive Market Forecast (2018-2023)
12.2.4 South America Female Contraceptive Market Forecast (2018-2023)
12.2.5 Middle East and Africa Female Contraceptive Market Forecast (2018-2023)
12.3 Female Contraceptive Market Forecast by Type (2018-2023)
12.3.1 Global Female Contraceptive Sales Forecast by Type (2018-2023)
12.3.2 Global Female Contraceptive Market Share Forecast by Type (2018-2023)
12.4 Female Contraceptive Market Forecast by Application (2018-2023)
12.4.1 Global Female Contraceptive Sales Forecast by Application (2018-2023)
12.4.2 Global Female Contraceptive Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Female Contraceptive Picture
Table Product Specifications of Female Contraceptive
Figure Global Sales Market Share of Female Contraceptive by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
